We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01234935
Recruitment Status : Completed
First Posted : November 4, 2010
Last Update Posted : January 9, 2018
Information provided by (Responsible Party):
Translational Oncology Research International

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 27, 2017
  Study Completion Date : November 27, 2017